NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.260
-0.030 (-2.33%)
At close: Oct 16, 2026, 4:00 PM EDT
1.280
+0.020 (1.59%)
After-hours: Oct 16, 2026, 4:29 PM EDT
NovaBridge Biosciences Employees
NovaBridge Biosciences had 30 employees as of December 31, 2025. The number of employees decreased by 2 or -6.25% compared to the previous year. That makes NovaBridge Biosciences the 37,049th largest employer in the world and 5,155th in the United States.
Employees
30
Change (1Y)
-2
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$3,918,467
Market Cap
146.16M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30 | -2 | -6.25% |
| Dec 31, 2024 | 32 | -188 | -85.45% |
| Dec 31, 2023 | 220 | -158 | -41.80% |
| Dec 31, 2021 | 378 | 150 | 65.79% |
| Dec 31, 2020 | 228 | 43 | 23.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Molecular Partners AG | 134 |
| Adagene | 128 |
| MediWound | 121 |
| Nkarta | 106 |
| Protara Therapeutics | 46 |
| Compass Therapeutics | 39 |
| Jyong Biotech | 27 |
NBP News
- 3 days ago - Wuhan Hiteck enters exclusive license agreement with Visara - TheFly
- 3 days ago - Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China - PRNewsWire
- 3 days ago - Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis - GlobeNewsWire
- 8 days ago - NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026 - GlobeNewsWire
- 4 weeks ago - NovaBridge Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 weeks ago - NovaBridge Biosciences Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director - GlobeNewsWire
- 7 weeks ago - NovaBridge Biosciences to Participate in September Investor Conferences - GlobeNewsWire